Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Triton has achieved GRAS (Generally Recognized As Safe) approval from the U.S. Food and Drug Administration and regulatory approval from the Singapore Food Agency[1]. The company commenced commercial-scale production of red and green algae[4] and has launched algae-infused pasta and superfood protein powder through its Too Good to be Foods division[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Triton Algae Innovations.